← Back to Search

wait-list control for Type 2 Diabetes

N/A

Waitlist Available

Led By Mary Sevick, PhD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6

Awards & highlights

Study Summary

This trial is looking at whether or not a text message intervention can help improve glycemic control in Chinese Americans with type 2 diabetes.

Eligible Conditions

Type 2 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Average Plasma Glucose Concentration measured by Hemoglobin A1c (HbA1c) Levels

Secondary outcome measures

Adapted Mediterranean Dietary Screener Score

International Physical Activity Questionnaire (IPAQ) Score

Minutes of Physical Activity as Measured by ActiGraph Watch

+3 more

Trial Design

2Treatment groups

Active Control

Group I: wait-list controlActive Control1 Intervention

3 measurement visits, baseline, 3, and 6 months

Group II: SMS interventionActive Control1 Intervention

3 measurement visits, baseline, 3, and 6 months

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,368 Previous Clinical Trials

839,666 Total Patients Enrolled

Mary Sevick, PhDPrincipal InvestigatorNYU Langone Health

Lu Hu, PhDPrincipal InvestigatorNYU Langone Health

4 Previous Clinical Trials

790 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility requirements for participating in this research endeavor?

"This study is recruiting 60 individuals who identify as Chinese immigrants or Americans, are aged 18-70 and have been diagnosed with type 2 diabetes. Critical criteria for consideration include: fluency in Mandarin, eagerness to watch two diabetes videos a week over 12 weeks, an inclination towards making lifestyle changes to manage their condition, agreement to wear ActiGraph monitors for 8 days, having HbA1c ≥ 7%, being able to use WeChat/text messages currently and readiness to receive T2D related texts."

Answered by AI

Does the eligibility criteria for this experiment encompass individuals who are over 20 years of age?

"This medical trial is accepting individuals between 18 and 70 years of age."

Answered by AI

Are there any openings for individuals to participate in this trial?

"Clinicaltrials.gov reveals that this medical trial is no longer recruiting patients, as the last update to its listing was on August 31st 2022. Nevertheless, there are presently 1,197 trials actively enrolling participants and seeking volunteers for their research studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Mobile Health Intervention to Reduce Diabetes Disparities in Chinese Americans

2021. "A Mobile Health Intervention to Reduce Diabetes Disparities in Chinese Americans". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03557697.